Zobrazeno 1 - 10
of 24
pro vyhledávání: '"S R, Acchiardo"'
A long-term, multicenter study of the efficacy and safety of paricalcitol in end-stage renal disease
Publikováno v:
Clinical nephrology. 56(4)
Paricalcitol is a vitamin D analog approved for the prevention and treatment of secondary hyperparathyroidism associated with chronic renal failure. This study was designed to evaluate the long-term efficacy and safety of paricalcitol. Additional ana
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::19d79b9d0db0afdf71182824263b21ba
https://pubmed.ncbi.nlm.nih.gov/11680662
https://pubmed.ncbi.nlm.nih.gov/11680662
Autor:
H M, Maung, L, Elangovan, J M, Frazão, J D, Bower, B J, Kelley, S R, Acchiardo, H J, Rodriguez, K C, Norris, J F, Sigala, M, Rutkowski, J A, Robertson, W G, Goodman, B S, Levine, R W, Chesney, R B, Mazess, D M, Kyllo, L L, Douglass, C W, Bishop, J W, Coburn
Publikováno v:
American journal of kidney diseases : the official journal of the National Kidney Foundation. 37(3)
Most reports on the effectiveness and side effects of oral versus parenteral calcitriol or alfacalcidol in hemodialysis patients with secondary hyperparathyroidism show no advantage of parenteral treatment. The efficacy and safety of intravenous doxe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9b72be3b854b5f89421f2f8f0c6df17d
https://pubmed.ncbi.nlm.nih.gov/11228177
https://pubmed.ncbi.nlm.nih.gov/11228177
Factors affecting erythropoietin production and correction of anemia in kidney transplant recipients
Publikováno v:
Clinical transplantation. 8(4)
Anemia does not correct in many kidney transplant recipients, probably due to iron deficiency or inadequate erythropoietin (Epo) production. We evaluated effects of iron (Fe) availability on correction of anemia in renal transplant recipients and sou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::34a9bb8915be18e165ebea40b27c4858
https://pubmed.ncbi.nlm.nih.gov/7949539
https://pubmed.ncbi.nlm.nih.gov/7949539
Autor:
S R, Acchiardo
Publikováno v:
Seminars in nephrology. 14(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b93b3e86c89fbbb9433779d3d4d2fa6f
https://pubmed.ncbi.nlm.nih.gov/8036362
https://pubmed.ncbi.nlm.nih.gov/8036362
Publikováno v:
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis. 8
Urea kinetics have been used to measure adequacy of hemodialysis. The role of urea kinetics in CAPD has not been clearly established. Using urea kinetics, we studied 71 hemodialysis and 71 CAPD patients. Age was 53 +/- 12 and 45.8 +/- 12 respectively
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d52539ede81c984871bcdd4e8ef86de3
https://pubmed.ncbi.nlm.nih.gov/1361852
https://pubmed.ncbi.nlm.nih.gov/1361852
Publikováno v:
ASAIO transactions. 37(3)
Multiple factors have been implicated in the hematologic response to erythropoietin (EPO). The authors studied 54 hemodialysis patients; 44 received 1.5 g of iron intravenously, 16 received oral iron for 12 weeks, and 24 were treated with EPO. Some p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::706a8d1712597ea7042eb1f98ae850cb
https://pubmed.ncbi.nlm.nih.gov/1751102
https://pubmed.ncbi.nlm.nih.gov/1751102
Autor:
S R, Acchiardo, A J, Hayden
Publikováno v:
ASAIO transactions. 37(3)
One important pathogenic factor in dialysis hypotension is the drop in plasma osmolality. Increasing the dialysate Na+ concentration decreases hypotensive episodes. The authors studied 39 patients being treated with high flux dialysis. During a 9 wee
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0edcedb5b0db19d1a2b773a2a3cb9693
https://pubmed.ncbi.nlm.nih.gov/1751081
https://pubmed.ncbi.nlm.nih.gov/1751081
Publikováno v:
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis. 7
Adequacy of CAPD has not been established. The recommendation is a Kt/V (K, total urea clearance in ml/min; t. time in minutes on dialysis; and V, total body water which is the volume of distribution of urea) greater than 1.5/week and/or a creatinine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c71440f2adcea1819bd3a14be50dba67
https://pubmed.ncbi.nlm.nih.gov/1680455
https://pubmed.ncbi.nlm.nih.gov/1680455
Publikováno v:
Pharmacotherapy. 11(4)
Patients with chronic renal failure are at considerable nutritional risk due to restricted diets, poor intake, and dialysis-related protein losses; therefore, they often require specialized nutrition support. It is difficult, however, to gauge the su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ce756f3ab96668254022028e6b122b2e
https://pubmed.ncbi.nlm.nih.gov/1923911
https://pubmed.ncbi.nlm.nih.gov/1923911
Publikováno v:
Journal of Investigative Medicine. 54:S257.3-S257
Introduction We present an instructive case of bleeding esophageal varices, which occurred as a complication of central venous dialysis catheter (CVC)-induced superior vena cava (SVC) stenosis. Case Report Our patient is a 34-year-old female with an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0c2e48e5af0952c2a3d93cbf23584b4a
https://doi.org/10.2310/6650.2005.x0008.8
https://doi.org/10.2310/6650.2005.x0008.8